Ownership: Caitlin Collins, Innate Immunotherapeutics

Caitlin Collins is an owner of Innate Immunotherapeutics

Title Investor
Is Current yes
Percent Stake 2%
Shares 5.2 Million
Updated about 7 years ago

Source Links